(Q60691416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

S Mammoliti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

C Caroti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

L Gallo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

language of work or name

English

0 references

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

93-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01806636

18 October 2019

exact match

0 references

cites work

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

12 December 2020

Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium

1 reference

12 December 2020

Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer

1 reference

12 December 2020

Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival

1 reference

12 December 2020

Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer

1 reference

12 December 2020

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

12 December 2020

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

1 reference

12 December 2020

5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

The emerging role of 5-fluorouracil and leucovorin in the treatment of advanced breast cancer. A review

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

1 reference

12 December 2020

Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patients

1 reference

12 December 2020

Effect of Age on Incidence of Breast Cancer in Females2

1 reference

12 December 2020

A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers

1 reference

12 December 2020

The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8750532%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference